세계의 암 지지요법 시장(2024-2028년)

Cancer Supportive Care Market 2024-2028

The cancer supportive care market is forecasted to grow by USD 6259.3 mn during 2023-2028, accelerating at a CAGR of 4.3% during the forecast period. The report on the cancer supportive care market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of cancer cases, many side effects associated with cancer treatment, and untapped potential in developing countries.

Technavio's cancer supportive care market is segmented as below:

By Therapeutic Area

• Chemotherapy-induced anemia
• Chemotherapy-induced neutropenia
• Cancer pain
• CINV
• Others

By Distribution Channel

• Hospitals pharmacies
• Drug stores and retail pharmacies
• Online providers

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advent of biosimilars in cancer-associated treatment as one of the prime reasons driving the cancer supportive care market growth during the next few years. Also, outsourcing of biosimilars manufacturing activities and adoption of various strategies will lead to sizable demand in the market.

The report on the cancer supportive care market covers the following areas:

• Cancer Supportive Care Market sizing
• Cancer Supportive Care Market forecast
• Cancer Supportive Care Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cancer supportive care market vendors that include Amgen Inc., Baxter International Inc., Bayer AG, Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Helsinn Healthcare SA, Heron Therapeutics Inc., Johnson and Johnson Services Inc., Kyowa Kirin Co. Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Purdue Pharma LP, RELIEF THERAPEUTICS Holding SA, Sanofi SA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the cancer supportive care market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Therapeutic Area
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Cancer Supportive Care Market 2018 - 2022
  • Historic Market Size - Data Table on Global Cancer Supportive Care Market 2018 - 2022 ($ million)
• 4.2 Therapeutic Area segment analysis 2018 - 2022
  • Historic Market Size - Therapeutic Area Segment 2018 - 2022 ($ million)
• 4.3 Distribution Channel segment analysis 2018 - 2022
  • Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Therapeutic Area

• 6.1 Market segments
  • Chart on Therapeutic Area - Market share 2023-2028 (%)
  • Data Table on Therapeutic Area - Market share 2023-2028 (%)
• 6.2 Comparison by Therapeutic Area
  • Chart on Comparison by Therapeutic Area
  • Data Table on Comparison by Therapeutic Area
• 6.3 Chemotherapy-induced anemia - Market size and forecast 2023-2028
  • Chart on Chemotherapy-induced anemia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Chemotherapy-induced anemia - Market size and forecast 2023-2028 ($ million)
  • Chart on Chemotherapy-induced anemia - Year-over-year growth 2023-2028 (%)
  • Data Table on Chemotherapy-induced anemia - Year-over-year growth 2023-2028 (%)
• 6.4 Chemotherapy-induced neutropenia - Market size and forecast 2023-2028
  • Chart on Chemotherapy-induced neutropenia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Chemotherapy-induced neutropenia - Market size and forecast 2023-2028 ($ million)
  • Chart on Chemotherapy-induced neutropenia - Year-over-year growth 2023-2028 (%)
  • Data Table on Chemotherapy-induced neutropenia - Year-over-year growth 2023-2028 (%)
• 6.5 Cancer pain - Market size and forecast 2023-2028
  • Chart on Cancer pain - Market size and forecast 2023-2028 ($ million)
  • Data Table on Cancer pain - Market size and forecast 2023-2028 ($ million)
  • Chart on Cancer pain - Year-over-year growth 2023-2028 (%)
  • Data Table on Cancer pain - Year-over-year growth 2023-2028 (%)
• 6.6 CINV - Market size and forecast 2023-2028
  • Chart on CINV - Market size and forecast 2023-2028 ($ million)
  • Data Table on CINV - Market size and forecast 2023-2028 ($ million)
  • Chart on CINV - Year-over-year growth 2023-2028 (%)
  • Data Table on CINV - Year-over-year growth 2023-2028 (%)
• 6.7 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.8 Market opportunity by Therapeutic Area
  • Market opportunity by Therapeutic Area ($ million)
  • Data Table on Market opportunity by Therapeutic Area ($ million)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
  • Chart on Distribution Channel - Market share 2023-2028 (%)
  • Data Table on Distribution Channel - Market share 2023-2028 (%)
• 7.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
• 7.3 Hospitals pharmacies - Market size and forecast 2023-2028
  • Chart on Hospitals pharmacies - Market size and forecast 2023-2028 ($ million)
  • Data Table on Hospitals pharmacies - Market size and forecast 2023-2028 ($ million)
  • Chart on Hospitals pharmacies - Year-over-year growth 2023-2028 (%)
  • Data Table on Hospitals pharmacies - Year-over-year growth 2023-2028 (%)
• 7.4 Drug stores and retail pharmacies - Market size and forecast 2023-2028
  • Chart on Drug stores and retail pharmacies - Market size and forecast 2023-2028 ($ million)
  • Data Table on Drug stores and retail pharmacies - Market size and forecast 2023-2028 ($ million)
  • Chart on Drug stores and retail pharmacies - Year-over-year growth 2023-2028 (%)
  • Data Table on Drug stores and retail pharmacies - Year-over-year growth 2023-2028 (%)
• 7.5 Online providers - Market size and forecast 2023-2028
  • Chart on Online providers - Market size and forecast 2023-2028 ($ million)
  • Data Table on Online providers - Market size and forecast 2023-2028 ($ million)
  • Chart on Online providers - Year-over-year growth 2023-2028 (%)
  • Data Table on Online providers - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)
  • Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.9 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.10 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.11 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 Amgen Inc.
  • Amgen Inc. - Overview
  • Amgen Inc. - Product / Service
  • Amgen Inc. - Key news
  • Amgen Inc. - Key offerings
• 12.4 Baxter International Inc.
  • Baxter International Inc. - Overview
  • Baxter International Inc. - Business segments
  • Baxter International Inc. - Key news
  • Baxter International Inc. - Key offerings
  • Baxter International Inc. - Segment focus
• 12.5 Bayer AG
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key news
  • Bayer AG - Key offerings
  • Bayer AG - Segment focus
• 12.6 Daiichi Sankyo Co. Ltd.
  • Daiichi Sankyo Co. Ltd. - Overview
  • Daiichi Sankyo Co. Ltd. - Product / Service
  • Daiichi Sankyo Co. Ltd. - Key news
  • Daiichi Sankyo Co. Ltd. - Key offerings
• 12.7 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
• 12.8 GlaxoSmithKline Plc
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key news
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Segment focus
• 12.9 Heron Therapeutics Inc.
  • Heron Therapeutics Inc. - Overview
  • Heron Therapeutics Inc. - Product / Service
  • Heron Therapeutics Inc. - Key offerings
• 12.10 Johnson and Johnson Services Inc.
  • Johnson and Johnson Services Inc. - Overview
  • Johnson and Johnson Services Inc. - Business segments
  • Johnson and Johnson Services Inc. - Key news
  • Johnson and Johnson Services Inc. - Key offerings
  • Johnson and Johnson Services Inc. - Segment focus
• 12.11 Kyowa Kirin Co. Ltd.
  • Kyowa Kirin Co. Ltd. - Overview
  • Kyowa Kirin Co. Ltd. - Product / Service
  • Kyowa Kirin Co. Ltd. - Key offerings
• 12.12 Merck and Co. Inc.
  • Merck and Co. Inc. - Overview
  • Merck and Co. Inc. - Business segments
  • Merck and Co. Inc. - Key news
  • Merck and Co. Inc. - Key offerings
  • Merck and Co. Inc. - Segment focus
• 12.13 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
• 12.14 Purdue Pharma LP
  • Purdue Pharma LP - Overview
  • Purdue Pharma LP - Product / Service
  • Purdue Pharma LP - Key offerings
• 12.15 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
• 12.16 Sun Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd. - Overview
  • Sun Pharmaceutical Industries Ltd. - Product / Service
  • Sun Pharmaceutical Industries Ltd. - Key news
  • Sun Pharmaceutical Industries Ltd. - Key offerings
• 12.17 Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key news
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
• 13.9 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations